36 results
8-K
EX-9.01
PRCT
Procept BioRobotics Corp
1 May 24
Results of Operations and Financial Condition
7:23am
and marketing expenses primarily to expand the commercial organization and variable compensation expense, increased research and development expenses … )
Three Months Ended March 31,
Revenue
Cost of sales
Gross profit
Operating expenses:
Research and development
Selling, general and administrative
Total
8-K
EX-9.01
PRCT
Procept BioRobotics Corp
27 Feb 24
Results of Operations and Financial Condition
4:07pm
was primarily due to expenses to expand the commercial organization, increased variable compensation expense and accelerated research and development … the commercial organization, and increased research and development and general and administrative expenses.
Net loss was $105.9 million for the full year 2023
8-K
EX-99.1
pdatdx mg
1 Nov 23
PROCEPT BioRobotics® Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
4:10pm
424B5
7g5l3e9i1csrsv7gap
3 Aug 23
Prospectus supplement for primary offering
4:01pm
424B5
lit7ffnpdl31l
1 Aug 23
Prospectus supplement for primary offering
4:08pm
8-K
EX-99.1
kemhfa
27 Jul 23
PROCEPT BioRobotics® Reports Second Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
7:09am
8-K
EX-99.1
6e53lk37vb73cd9bno1t
27 Apr 23
PROCEPT BioRobotics Reports First Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
7:02am
8-K
EX-99.1
4zh6kuhzn nij2evy67s
3 Nov 22
PROCEPT BioRobotics Reports Third Quarter 2022 Financial Results and Increases 2022 Revenue Guidance
4:10pm
8-K
EX-10.1
t10n6ccj5xy0
11 Oct 22
Entry into a Material Definitive Agreement
7:33am
8-K
EX-99.1
40yk942m
4 Aug 22
PROCEPT BioRobotics Reports Second Quarter 2022 Financial Results and Increases 2022 Revenue Guidance
5:22pm
8-K
EX-99.1
dvehr00f
5 May 22
PROCEPT BioRobotics Reports First Quarter 2022 Financial Results and Increases 2022 Revenue Guidance
12:00am